Aldosterone
|
| Names |
| IUPAC name
11β,21-Dihydroxy-3,20-dioxopregn-4-en-18-al
|
| Identifiers |
|
CAS Number
|
52-39-1 Y |
| ChEBI |
CHEBI:27584 Y |
| ChEMBL |
ChEMBL273453 Y |
| ChemSpider |
5633 Y |
| DrugBank |
DB04630 Y |
| ECHA InfoCard |
100.000.128 |
|
IUPHAR/BPS
|
2872 |
| Jmol 3D model |
Interactive image |
| KEGG |
C01780 Y |
| MeSH |
Aldosterone |
| PubChem |
5839 |
InChI
-
InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1 Y
Key: PQSUYGKTWSAVDQ-ZVIOFETBSA-N Y
-
InChI=1/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1
Key: PQSUYGKTWSAVDQ-ZVIOFETBBV
|
SMILES
-
O=C(CO)[C@@H]4[C@@]3(C=O)C[C@H](O)[C@@H]2[C@@]1(/C(=C\C(=O)CC1)CC[C@H]2[C@@H]3CC4)C
|
| Properties |
|
Chemical formula
|
C21H28O5 |
| Molar mass |
360.45 g·mol−1 |
| Pharmacology |
|
ATC code
|
H02AA01 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
| N verify (what is YN ?) |
| Infobox references |
|
|
Aldosterone is a steroid hormone, "the main mineralocorticoid hormone",[1]:50 produced by the outer section (zona glomerulosa) of the adrenal cortex in the adrenal gland.[2][3] It plays a central role in the regulation of the plasma sodium (Na+), the extracellular potassium (K+) and arterial blood pressure. It does so mainly by acting on the distal tubules and collecting ducts of the nephron, increasing reabsorption and excretion of ions out of and into the tubular fluids of the kidney, to cause the conservation of sodium, secretion of potassium, and thereby indirectly influencing water retention or loss, and influencing blood pressure and blood volume.[4] When dysregulated, aldosterone is pathogenic and contributes to the development and progression of cardiovascular and renal disease.[3] Aldosterone has exactly the opposite function of the atrial natriuretic hormone secreted by the heart.[4]
Aldosterone is part of the renin–angiotensin system. It has a plasma half-life of under 20 minutes.[5] Drugs that interfere with the secretion or action of aldosterone are in use as antihypertensives, like lisinopril, which lowers blood pressure by blocking the angiotensin-converting enzyme (ACE), leading to lower aldosterone secretion. The net effect of these drugs is to reduce sodium and water retention but increase retention of potassium. Another example is spironolactone, a potassium-sparing diuretic of the steroidal spirolactone group, which decreases blood pressure by releasing fluid from the body while retaining potassium.
Aldosterone was first isolated by Simpson and Tait in 1953.[6]
Contents
- 1 Synthesis
- 2 Function
- 3 Location of receptors
- 4 Control of aldosterone release from the adrenal cortex
- 4.1 Major regulators
- 4.1.1 The role of the renin-angiotensin system
- 4.1.2 The plasma concentration of potassium
- 4.1.3 ACTH
- 4.2 Miscellaneous regulators
- 4.2.1 The role of sympathetic nerves
- 4.2.2 The role of baroreceptors
- 4.2.3 The plasma concentration of sodium
- 4.3 Aldosterone feedback
- 5 Associated clinical conditions
- 5.1 Hyperaldosteronism
- 5.2 Hypoaldosteronism
- 6 Additional images
- 7 See also
- 8 References
- 9 External links
Synthesis
The corticosteroids are synthesized from cholesterol within the zona glomerulosa of adrenal cortex. Most steroidogenic reactions are catalysed by enzymes of the cytochrome P450 family. They are located within the mitochondria and require adrenodoxin as a cofactor (except 21-hydroxylase and 17α-hydroxylase).
Aldosterone and corticosterone share the first part of their biosynthetic pathways. The last parts are mediated either by the aldosterone synthase (for aldosterone) or by the 11β-hydroxylase (for corticosterone). These enzymes are nearly identical (they share 11β-hydroxylation and 18-hydroxylation functions), but aldosterone synthase is also able to perform an 18-oxidation. Moreover, aldosterone synthase is found within the zona glomerulosa at the outer edge of the adrenal cortex; 11β-hydroxylase is found in the zona glomerulosa and zona fasciculata.
Steroidogenesis, showing aldosterone synthesis at upper-right corner
Note: aldosterone synthase is absent in other sections of the adrenal gland.
Stimulation
Aldosterone synthesis is stimulated by several factors:
- increase in the plasma concentration of angiotensin III, a metabolite of angiotensin II
- increase in plasma angiotensin II, ACTH, or potassium levels, which are present in proportion to plasma sodium deficiencies. (The increased potassium level works to regulate aldosterone synthesis by depolarizing the cells in the zona glomerulosa, which opens the voltage-dependent calcium channels.) The level of angiotensin II is regulated by angiotensin I, which is in turn regulated by renin, a hormone secreted in the kidneys.
- Serum potassium concentrations are the most potent stimulator of aldosterone secretion.
- the ACTH stimulation test, which is sometimes used to stimulate the production of aldosterone along with cortisol to determine whether primary or secondary adrenal insufficiency is present. However, ACTH has only a minor role in regulating aldosterone production; with hypopituitarism there is no atrophy of the zona glomerulosa.
- plasma acidosis
- the stretch receptors located in the atria of the heart. If decreased blood pressure is detected, the adrenal gland is stimulated by these stretch receptors to release aldosterone, which increases sodium reabsorption from the urine, sweat, and the gut. This causes increased osmolarity in the extracellular fluid, which will eventually return blood pressure toward normal.
- adrenoglomerulotropin, a lipid factor, obtained from pineal extracts. It selectively stimulates secretion of aldosterone.[7]
The secretion of aldosterone has a diurnal rhythm.[8]
Function
Aldosterone is the primary of several endogenous members of the class of mineralocorticoids in humans. Deoxycorticosterone is another important member of this class. Aldosterone tends to promote Na+ and water retention, and lower plasma K+ concentration by the following mechanisms:
- Acting on the nuclear mineralocorticoid receptors (MR) within the principal cells of the distal tubule and the collecting duct of the kidney nephron, it upregulates and activates the basolateral Na+/K+ pumps, which pumps three sodium ions out of the cell, into the interstitial fluid and two potassium ions into the cell from the interstitial fluid. This creates a concentration gradient which results in reabsorption of sodium (Na+) ions and water (which follows sodium) into the blood, and secreting potassium (K+) ions into the urine (lumen of collecting duct).
- Aldosterone upregulates epithelial sodium channels (ENaCs) in the collecting duct and the colon, increasing apical membrane permeability for Na+ and thus absorption.
- Cl− is reabsorbed in conjunction with sodium cations to maintain the system's electrochemical balance.
- Aldosterone stimulates the secretion of K+ into the tubular lumen.[9]
- Aldosterone stimulates Na+ and water reabsorption from the gut, salivary and sweat glands in exchange for K+.
- Aldosterone stimulates secretion of H+ via the H+/ATPase in the intercalated cells of the cortical collecting tubules
- Aldosterone upregulates expression of NCC in the distal convoluted tubule chronically and its activity acutely.[10]
Aldosterone is responsible for the reabsorption of about 2% of filtered sodium in the kidneys, which is nearly equal to the entire sodium content in human blood under normal glomerular filtration rates.[11]
Aldosterone, probably acting through mineralocorticoid receptors, may positively influence neurogenesis in the dentate gyrus.[12]
Location of receptors
Steroid receptors are intracellular. The aldosterone mineralocorticoid receptor complex binds on the DNA to specific hormone response element, which leads to gene specific transcription.
Some of the transcribed genes are crucial for transepithelial sodium transport, including the three subunits of the epithelial sodium channel (ENaC), the Na+/K+ pumps and their regulatory proteins serum and glucocorticoid-induced kinase, and channel-inducing factor, respectively.
The mineralocorticoid receptor is stimulated by both aldosterone and cortisol, but a mechanism protects the body from excess aldosterone receptor stimulation by glucocorticoids (such as cortisol), which happen to be present at much higher concentrations than mineralocorticoids in the healthy individual. The mechanism consists of an enzyme called 11 β-hydroxysteroid dehydrogenase (11 β-HSD). This enzyme co-localizes with intracellular adrenal steroid receptors and converts cortisol into cortisone, a relatively inactive metabolite with little affinity for the MR. Liquorice, which contains glycyrrhetinic acid, can inhibit 11 β-HSD and lead to a mineralocorticoid excess syndrome.
Control of aldosterone release from the adrenal cortex
The renin-angiotensin system, showing role of aldosterone between the adrenal glands and the kidneys
[13]
Major regulators
The role of the renin-angiotensin system
Angiotensin is involved in regulating aldosterone and is the core regulation.[14] Angiotensin II acts synergistically with potassium, and the potassium feedback is virtually inoperative when no angiotensin II is present.[15] A small portion of the regulation resulting from angiotensin II must take place indirectly from decreased blood flow through the liver due to constriction of capillaries.[16] When the blood flow decreases so does the destruction of aldosterone by liver enzymes.
Although sustained production of aldosterone requires persistent calcium entry through low-voltage-activated Ca2+ channels, isolated zona glomerulosa cells are considered nonexcitable, with recorded membrane voltages that are too hyperpolarized to permit Ca2+ channels entry.[3] However, mouse zona glomerulosa cells within adrenal slices spontaneously generate membrane potential oscillations of low periodicity; this innate electrical excitability of zona glomerulosa cells provides a platform for the production of a recurrent Ca2+ channels signal that can be controlled by angiotensin II and extracellular potassium, the 2 major regulators of aldosterone production.[3] Voltage-gated Ca2+ channels have been detected in the zona glomerulosa of the human adrenal, which suggests that Ca2+ channel blockers may directly influence the adrenocortical biosynthesis of aldosterone in vivo.[17]
The plasma concentration of potassium
The amount of aldosterone secreted is a direct function of the serum potassium[18][19] as probably determined by sensors in the carotid artery.[20][21]
ACTH
ACTH, a pituitary peptide, also has some stimulating effect on aldosterone, probably by stimulating the formation of deoxycorticosterone, a precursor of aldosterone.[22] Aldosterone is increased by blood loss,[23] pregnancy,[24] and possibly by further circumstances such as physical exertion, endotoxin shock, and burns.[25][26]
Miscellaneous regulators
The role of sympathetic nerves
The aldosterone production is also affected to one extent or another by nervous control, which integrates the inverse of carotid artery pressure,[20] pain, posture,[24] and probably emotion (anxiety, fear, and hostility)[27] (including surgical stress).[28] Anxiety increases aldosterone,[27] which must have evolved because of the time delay involved in migration of aldosterone into the cell nucleus.[29] Thus, there is an advantage to an animal's anticipating a future need from interaction with a predator, since too high a serum content of potassium has very adverse effects on nervous transmission.
The role of baroreceptors
Pressure-sensitive baroreceptors are found in the vessel walls of nearly all large arteries in the thorax and neck, but are particularly plentiful in the sinuses of the carotid arteries and in the arch of the aorta. These specialized receptors are sensitive to changes in mean arterial pressure. An increase in sensed pressure results in an increased rate of firing by the baroreceptors and a negative feedback response, lowering systemic arterial pressure. Aldosterone release causes sodium and water retention, which causes increased blood volume, and a subsequent increase in blood pressure, which is sensed by the baroreceptors.[30] To maintain normal homeostasis these receptors also detect low blood pressure or low blood volume, causing aldosterone to be released. This results in sodium retention in the kidney, leading to water retention and increased blood volume.[31]
The plasma concentration of sodium
Aldosterone is a function of the inverse of the sodium intake as sensed via osmotic pressure.[32] The slope of the response of aldosterone to serum potassium is almost independent of sodium intake.[33] Aldosterone is much increased at low sodium intakes, but the rate of increase of plasma aldosterone as potassium rises in the serum is not much lower at high sodium intakes than it is at low. Thus, the potassium is strongly regulated at all sodium intakes by aldosterone when the supply of potassium is adequate, which it usually is in primitive diets.
Aldosterone feedback
Feedback by aldosterone concentration itself is of a nonmorphological character (that is, other than changes in the cells' number or structure) and is poor, so the electrolyte feedbacks predominate, short term.[25]
Associated clinical conditions
Hyperaldosteronism is abnormally increased levels of aldosterone, while hypoaldosteronism is abnormally decreased levels of aldosterone.
A measurement of aldosterone in blood may be termed a plasma aldosterone concentration (PAC), which may be compared to plasma renin activity (PRA) as an aldosterone-to-renin ratio.
Hyperaldosteronism
Primary aldosteronism, also known as primary hyperaldosteronism, is characterized by the overproduction of aldosterone by the adrenal glands,[34] when not a result of excessive renin secretion. It leads to arterial hypertension (high blood pressure) associated with hypokalemia, usually a diagnostic clue. Secondary hyperaldosteronism, on the other hand, is due to overactivity of the renin-angiotensin system.
Conn's syndrome is primary hyperaldosteronism caused by an aldosterone-producing adenoma.
Depending on cause and other factors, hyperaldosteronism can be treated by surgery and/or medically, such as by aldosterone antagonists.
Hypoaldosteronism
An ACTH stimulation test for aldosterone can help in determining the cause of hypoaldosteronism, with a low aldosterone response indicating a primary hypoaldosteronism of the adrenals, while a large response indicating a secondary hypoaldosteronism.
Additional images
-
Corticosteroid biosynthetic pathway in rat
-
See also
References
- ^ Jaisser F, Farman N (January 2016). "Emerging Roles of the Mineralocorticoid Receptor in Pathology". Pharmacological Reviews. 68: 49–75. doi:10.1124/pr.115.011106.
- ^ Marieb, Elaine Nicpon; Hoehn, Katja (2013). "Chapter 16". Human anatomy & physiology (9th ed.). Boston: Pearson. pp. 629, Question 14. OCLC 777127809.
- ^ a b c d Hu C, Rusin CG, Tan Z, Guagliardo NA, Barrett PQ (June 2012). "Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electricaloscillators.". J Clin Invest. 122 (6): 2046–2053. doi:10.1172/JCI61996. PMID 22546854.
- ^ a b Marieb Human Anatomy & Physiology 9th edition, chapter:16, page:629, question number:14
- ^ "Pharmacokinetics of Corticosteroids". 2003. Retrieved 15 June 2016.
- ^ Williams JS, Williams GH (June 2003). "50th anniversary of aldosterone". J Clin Endocrinol Metab. 88 (6): 2364–72. doi:10.1210/jc.2003-030490. PMID 12788829.
- ^ Farrell G (May 1960). "Adrenoglomerulotropin". Circulation. 21 (5): 1009–15. doi:10.1161/01.CIR.21.5.1009. PMID 13821632.
- ^ Hurwitz S, Cohen RJ, Williams GH (April 2004). "Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest". J App Physiol. 96 (4): 1406–14. doi:10.1152/japplphysiol.00611.2003. PMID 14660513.
- ^ Palmer, LG; Frindt, G (2000). "Aldosterone and potassium secretion by the cortical collecting duct". Kidney International. 57 (4): 1324–8. doi:10.1046/j.1523-1755.2000.00970.x. PMID 10760062.
- ^ Ko, Benjamin; Mistry, Abinash C.; Hanson, Lauren; Mallick, Rickta; Wynne, Brandi M.; Thai, Tiffany L.; Bailey, James L.; Klein, Janet D.; Hoover, Robert S. (2013-09-01). "Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway". American Journal of Physiology. Renal Physiology. 305 (5): F645–652. doi:10.1152/ajprenal.00053.2013. ISSN 1522-1466. PMC 3761211. PMID 23739593.
- ^ Sherwood, Lauralee (2001). Human physiology: from cells to systems. Pacific Grove, CA: Brooks/Cole. ISBN 0-534-56826-2. OCLC 43702042.
- ^ Fischer AK, von Rosenstiel P, Fuchs E, Goula D, Almeida OF, Czéh B (August 2002). "The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat". Brain Res. 947 (2): 290–3. doi:10.1016/S0006-8993(02)03042-1. PMID 12176172.
- ^ Page 866-867 (Integration of Salt and Water Balance) and 1059 (The Adrenal Gland) in: Walter F. Boron (2003). Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. p. 1300. ISBN 1-4160-2328-3.
- ^ Williams GH, Dluhy RG (November 1972). "Aldosterone biosynthesis. Interrelationship of regulatory factors". Am J Med. 53 (5): 595–605. doi:10.1016/0002-9343(72)90156-8. PMID 4342886.
- ^ Pratt JH (September 1982). "Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog". J Clin Invest. 70 (3): 667–72. doi:10.1172/JCI110661. PMC 370270. PMID 6286729.
- ^ Messerli FH, Nowaczynski W, Honda M, et al. (February 1977). "Effects of angiotensin II on steroid metabolism and hepatic blood flow in man". Circulation Research. 40 (2): 204–7. doi:10.1161/01.RES.40.2.204. PMID 844145.
- ^ Felizola SJ, Maekawa T, Nakamura Y, Satoh F, Ono Y, Kikuchi K, Aritomi S, Ikeda K, Yoshimura M, Tojo K, Sasano H (2014). "Voltage-gated calcium channels in the human adrenal and primary aldosteronism.". J Steroid Biochem Mol Biol. 144 (part B): 410–416. doi:10.1016/j.jsbmb.2014.08.012. PMID 25151951.
- ^ Bauer JH, Gauntner WC (March 1979). "Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man". Kidney Int. 15 (3): 286–93. doi:10.1038/ki.1979.37. PMID 513492.
- ^ Linas SL, Peterson LN, Anderson RJ, Aisenbrey GA, Simon FR, Berl T (June 1979). "Mechanism of renal potassium conservation in the rat". Kidney Int. 15 (6): 601–11. doi:10.1038/ki.1979.79. PMID 222934.
- ^ a b Gann DS Mills IH Bartter 1960 On the hemodynamic parameter mediating increase in aldosterone secretion in the dog. Fed. Proceedings 19; 605–610.
- ^ Gann DS, Cruz JF, Casper AG, Bartter FC (May 1962). "Mechanism by which potassium increases aldosterone secretion in the dog". Am J Physiol. 202: 991–6. PMID 13896654.
- ^ Brown RD, Strott CA, Liddle GW (June 1972). "Site of stimulation of aldosterone biosynthesis by angiotensin and potassium". J Clin Invest. 51 (6): 1413–8. doi:10.1172/JCI106937. PMC 292278. PMID 4336939.
- ^ Ruch TC Fulton JF 1960 Medical Physiology and Biophysics. W.B. Saunders and Co., Phijl & London. On p1099.
- ^ a b Farrell G (October 1958). "Regulation of aldosterone secretion". Physiological Reviews. 38 (4): 709–28. PMID 13590935.
- ^ a b Vecsei, Pál; Gláz, Edith (1971). Aldosterone. New York: Pergamon Press. ISBN 0-08-013368-1. OCLC 186705.
- ^ Farrell GL, Rauschkolb EW (November 1956). "Evidence for diencephalic regulation of aldosterone secretion". Endocrinology. 59 (5): 526–31. doi:10.1210/endo-59-5-526. PMID 13375573. on 529
- ^ a b Venning EH, DyrenfurthY I, Beck JC (August 1957). "Effect of anxiety upon aldosterone excretion in man". J Clin Endocrinol Metab. 17 (8): 1005–8. doi:10.1210/jcem-17-8-1005. PMID 13449153.
- ^ Elman R, Shatz BA, Keating RE, Weichselbaum TE (July 1952). "Intracellular and Extracellular Potassium Deficits in Surgical Patients". Annals of Surgery. 136 (1): 111–31. doi:10.1097/00000658-195208000-00013. PMC 1802239. PMID 14934025.
- ^ Sharp GUG Leaf A 1966 in; Recent Progress in Hormone Research. (Pincus G, ed.
- ^ Copstead, E. C. & Banasik, J. L. (2010.) Pathophysiology. (4th ed.). St. Louis, Mo: Saunders Elsevier.
- ^ Marieb, E. N. (2004) Human anatomy and physiology (6th ed) San Francisco: Pearson Benjamin Cummings.
- ^ Schneider EG, Radke KJ, Ulderich DA, Taylor RE (April 1985). "Effect of osmolality on aldosterone secretion". Endocrinology. 116 (4): 1621–6. doi:10.1210/endo-116-4-1621. PMID 3971930.
- ^ Dluhy RG, Axelrod L, Underwood RH, Williams GH (August 1972). "Studies of the control of plasma aldosterone concentration in normal man: II. Effect of dietary potassium and acute potassium infusion". J Clin Invest. 51 (8): 1950–7. doi:10.1172/JCI107001. PMC 292351. PMID 5054456.
- ^ Conn JW, Louis LH (1955). "Primary aldosteronism: a new clinical entity". Trans. Assoc. Am. Physicians. 68: 215–31; discussion, 231–3. PMID 13299331.
External links
- Aldosterone at Lab Tests Online
|
Hormones
|
|
Endocrine
glands |
|
Hypothalamic-
pituitary
|
|
Hypothalamus
|
- GnRH
- TRH
- Dopamine
- CRH
- GHRH
- Somatostatin (GHIH)
- MCH
|
|
|
Posterior pituitary
|
|
|
|
Anterior pituitary
|
- FSH
- LH
- TSH
- Prolactin
- POMC
- CLIP
- ACTH
- MSH
- Endorphins
- Lipotropin
- GH
|
|
|
|
Adrenal axis
|
- Adrenal cortex
- aldosterone
- cortisol
- cortisone
- DHEA
- testosterone
- Adrenal medulla
- epinephrine
- norepinephrine
|
|
|
Thyroid
|
- Thyroid hormone
- Calcitonin
- Thyroid axis
|
|
|
Parathyroid
|
|
|
|
|
Gonadal axis
|
|
Testis
|
|
|
|
Ovary
|
- estradiol
- progesterone
- activin and inhibin
- relaxin (pregnancy)
|
|
|
Placenta
|
- hCG
- HPL
- estrogen
- progesterone
|
|
|
|
Pancreas
|
- glucagon
- insulin
- amylin
- somatostatin
- pancreatic polypeptide
|
|
|
Pineal gland
|
- melatonin
- N,N-dimethyltryptamine
- 5-methoxy-N,N-dimethyltryptamine
|
|
|
| Other |
|
Thymus
|
- Thymosins
- Thymosin α1
- Beta thymosins
- Thymopoietin
- Thymulin
|
|
|
Digestive system
|
|
Stomach
|
|
|
|
Duodenum
|
- CCK
- Incretins
- secretin
- motilin
- VIP
|
|
|
Ileum
|
- enteroglucagon
- peptide YY
|
|
|
Liver/other
|
- Insulin-like growth factor
|
|
|
|
Adipose tissue
|
- leptin
- adiponectin
- resistin
|
|
|
Skeleton
|
|
|
|
Kidney
|
- JGA (renin)
- peritubular cells
- calcitriol
- prostaglandin
|
|
|
Heart
|
|
|
|
Physiology of the kidneys and acid-base physiology
|
|
| Renal function |
| Secretion |
- clearance
- Pharmacokinetics
- Clearance of medications
- Urine flow rate
|
|
| Reabsorption |
- Solvent drag
- sodium
- chloride
- urea
- glucose
- oligopeptides
- protein
|
|
| Renal function |
- Glomerular filtration rate
- Creatinine clearance
- Renal clearance ratio
- Urea reduction ratio
- Kt/V
- Standardized Kt/V
- Measures of dialysis
- PAH clearance (Effective renal plasma flow
- Extraction ratio)
|
|
| Filtration |
- Renal blood flow
- Ultrafiltration
- Countercurrent exchange
- Filtration fraction
|
|
|
| Hormones |
- Antidiuretic hormone
- Aldosterone
- Atrial natriuretic peptide
- Renin
- Erythropoietin
- Calcitriol
- Prostaglandins
|
|
| Acid-base balance |
- Fluid balance
- Darrow Yannet diagram
Body water: Intracellular fluid/Cytosol
- Extracellular fluid
- (Interstitial fluid
- Plasma
- Transcellular fluid)
- Base excess
- Davenport diagram
- Anion gap
- Arterial blood gas
- Winter's formula
- Buffering
- Bicarbonate buffer system
- Respiratory compensation
- Renal compensation
|
|
| Other |
- Fractional sodium excretion
- BUN-to-creatinine ratio
- Tubuloglomerular feedback
- Natriuresis
- Urine
|
|
Mineralocorticoids and antimineralocorticoids (H02)
|
|
| Mineralocorticoids |
- 11-Deoxycorticosterone (desoxycortone)
- 11-Deoxycortisol (cortodoxone)
- Aldosterone
- Corticosterone
- Cortisol (hydrocortisone)
- Desoxycortone acetate
- Desoxycortone enanthate
- Fludrocortisone
- Fludrocortisone acetate
|
|
| Antimineralocorticoids |
- Steroidal:
- Canrenoate potassium (potassium canrenoate)
- Canrenoic acid
- Canrenone
- Drospirenone
- Dydrogesterone
- Eplerenone
- Gestodene
- Progesterone
- Quingestrone
- Spironolactone
- Non-steroidal: Amlodipine
- Benidipine
- Felodipine
- Finerenone
- Nifedipine
- Nimodipine
- Nitrendipine
|
|
| Synthesis modifiers |
- Acetoxolone
- Aminoglutethimide
- Carbenoxolone
- Enoxolone
- Ketoconazole
- Metyrapone
- Mitotane
- Trilostane
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
See also: Androgens and antiandrogens • Estrogens and antiestrogens • Progestogens and antiprogestogens • Glucocorticoids and antiglucocorticoids
|
|
Mineralocorticoid receptor modulators
|
|
| MR |
|
Agonists
|
- 11-Deoxycorticosterone (desoxycortone)
- 11-Deoxycortisol (cortodoxone)
- 16α,18-Dihydroxy-11-deoxycorticosterone
- 17-Hydroxyaldosterone
- 18-Hydroxy-11-deoxycorticosterone
- 19-Norprogesterone
- Aldosterone
- Corticosterone
- Desoxycortone acetate
- Desoxycortone enanthate
- Desoxycortone glucoside
- Desoxycortone pivalate
- Hydrocortisone (cortisol)
- Fludrocortisone
- Fludrocortisone acetate
- Mometasone furoate
- Prednisolone
- Prednisone
|
|
|
Antagonists
|
- Steroidal: 3α-Hydroxytibolone
- 3β-Hydroxytibolone
- 6β-Hydroxy-7α-thiomethylspironolactone
- 7α-Thiomethylspironolactone
- 17-Hydroxyprogesterone
- 18-Deoxyaldosterone
- Canrenoate potassium (potassium canrenoate)
- Canrenoic acid
- Canrenone
- Dicirenone
- Dimethisterone
- Drospirenone
- Dydrogesterone
- Eplerenone
- Gestodene
- Guggulsterone
- Medrogestone
- Mespirenone
- Mexrenoate potassium
- Mexrenoic acid
- Mexrenone
- Oxprenoic acid
- Oxprenoate potassium (RU-28318)
- Pregnenolone
- Progesterone
- Prorenoate potassium
- Prorenoic acid (prorenoate)
- Prorenone
- RO-14-9012
- RU-26752
- SC-5233
- SC-8109
- SC-11927
- SC-19886
- SC-24813
- SC-25152
- SC-26519
- SC-27169
- Spirorenone
- Spironolactone
- Spiroxasone
- Tibolone
- Trimegestone
- ZK-91587
- ZK-97894
- Non-steroidal: Amlodipine
- Apararenone
- Benidipine
- BR-4628
- Esaxerenone
- Felodipine
- Finerenone
- Nifedipine
- Nimodipine
- Nitrendipine
- PF-03882845
- SM-368229
|
|
|
|
See also: Androgenics • Estrogenics • Glucocorticoidics • Progestogenics • Steroid hormone metabolism modulators
|
